Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
---|
01/07/2009 | CN100448874C N-aroyl cyclic amines |
01/07/2009 | CN100448870C 2-aminoquinoline derivative |
01/07/2009 | CN100448868C Tri-substituted heteroaryls and methods of making and using the same |
01/07/2009 | CN100448687C Imaging system |
01/06/2009 | US7473790 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same |
01/06/2009 | US7473701 Substituted indazoles, compositions containing them, method of production and use |
01/06/2009 | US7473695 4-imidazolin-2-one compounds |
01/06/2009 | US7473691 Pyrazole compounds useful as protein kinase inhibitors |
01/06/2009 | US7473686 Thrombopoietin mimetics |
01/06/2009 | CA2494321C 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same |
01/06/2009 | CA2478374C N3 alkylated benzimidazole derivatives as mek inhibitors |
01/06/2009 | CA2421008C Substituted heterocyclic compounds for treating multidrug resistance |
01/06/2009 | CA2369504C Pyrazole compositions useful as inhibitors of erk |
01/06/2009 | CA2227851C Novel 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives |
01/06/2009 | CA2216546C 1,3-dihydro-1-(phenylalkenyl)-2h-imidazol-2-one derivatives having pde iv and cytokine inhibiting activity |
01/02/2009 | DE60224401T2 Hepatitis c virus polymerase inhibitoren mit heterobicylischer struktur Hepatitis C virus polymerase inhibitors with heterobicylischer structure |
01/01/2009 | US20090005580 Compounds, compositions and methods |
01/01/2009 | US20090005431 Substituted pyrrolidines |
01/01/2009 | US20090005391 Tricyclo Substituted Amides |
12/31/2008 | WO2009002469A1 Phthalazine compounds, compositions and methods of use |
12/31/2008 | WO2009001968A1 Benzazepine derivatives useful as vasopressin antagonists |
12/31/2008 | WO2009001949A1 Pyrazolone derivative |
12/31/2008 | WO2009001915A1 Substituted imidazole compound and use thereof |
12/31/2008 | WO2009001730A1 Novel compound having β secretase inhibitory activity |
12/31/2008 | WO2009001369A1 An improved process for the preparation of alfuzosin hydrochloride |
12/31/2008 | WO2009001127A1 Cyanocyclopropylcarboxamides as cathepsin inhibitors |
12/31/2008 | WO2009000878A1 Kallikrein 7 modulators |
12/31/2008 | WO2009000757A1 Piperazine compounds with herbicidal action |
12/31/2008 | WO2008135181A3 Insecticidal substituted 2-aminoindanes |
12/31/2008 | WO2008082487A3 Novel jnk inhibitors |
12/31/2008 | EP2009006A1 Ureide derivative and use thereof for medical purposes |
12/31/2008 | EP2007789A2 Hcv/hiv inhibitors and their uses |
12/31/2008 | EP2007756A2 Modulators of atp-binding cassette transporters |
12/31/2008 | EP2007755A2 Fused ring thrombin receptor antagonists |
12/31/2008 | EP2007751A1 Azabicyclo [3. 1. o] hexyl derivatives as modulators of dopamine d3 receptors |
12/31/2008 | EP2007749A2 Tetralines antagonists of the h-3 receptor |
12/31/2008 | EP2007748A2 Synthesis and regioselective substitution of 6-halo- and 6-alkoxy nicotine derivatives |
12/31/2008 | EP2007734A1 Enzyme inhibitors |
12/31/2008 | EP2007729A1 Substituted tetrahydroisoquinoline compounds, their preparation and use in medicaments |
12/31/2008 | EP2007725A2 Non-peptidic renin inhibitors nitroderivatives |
12/31/2008 | EP2007716A1 Aryl and heteroaryl sulphonamides as growth hormone secretagogue receptor agonists |
12/31/2008 | EP1765809B1 Xanthine derivatives useful as muscarinic receptor antagonists |
12/31/2008 | EP1737863B1 2-cyanopyrrolidinecarboxamides as dipeptidyl peptidase-iv inhibitors |
12/31/2008 | EP1727812B1 Novel cycloalkyl-containing 5-acylindolinones, their preparation and their use as pharmaceutical products |
12/31/2008 | EP1680415B1 Pyrrolidinyl urea derivatives as angiogenesis inhibitors |
12/31/2008 | EP1546099B1 3,6-disubstituted azabicyclo 3.1.0 hexane derivatives useful as muscarinic receptor antagonists |
12/31/2008 | EP1051397B1 Method for preparing an n- (aliphatic or aromatic)carbonyl -2-aminoacetamide compound and a cyclyzed compound |
12/31/2008 | CN101336240A Salt of sulfinylbenzimidazole compound, and crystal and amorphous form thereof |
12/31/2008 | CN100447136C New spirotricyclic derivatives and their use as phosphodiesterase-7-inhibitors |
12/31/2008 | CN100446767C Use of GAL3 receptor antagonists for treatment of. depression and/or anxiety and compounds useful in such methods |
12/31/2008 | CA2691932A1 Use of compounds for preparing anti-tuberculosis agents |
12/31/2008 | CA2691849A1 Kallikrein 7 modulators |
12/31/2008 | CA2691772A1 Crystalline polymorph of exemestane |
12/31/2008 | CA2690378A1 Phthalazine compounds, compositions and methods of use |
12/31/2008 | CA2690335A1 Benzazepine derivatives useful as vasopressin antagonists |
12/31/2008 | CA2690145A1 Crystalline polymorph of 7-ethyl-10-hydroxycamptothecin |
12/31/2008 | CA2686224A1 Piperazine compounds having herbicidal action |
12/30/2008 | US7470807 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate |
12/30/2008 | US7470798 7,8-bicycloalkyl-chroman derivatives |
12/30/2008 | US7470722 For treating disease, such as cancer, neurological disorders, including polyglutamine-repeat disorders, anemias, thalassemias, inflammatory conditions, autoimmune diseases and cardiovascular conditions |
12/30/2008 | US7470712 Amino-benzazoles as P2Y1 receptor inhibitors |
12/30/2008 | US7470711 Piperidinyl substituted cyclohexane-1,4-diamines |
12/30/2008 | US7470710 Such as 2-Benzofuranylmethyl-1-((5-(4-fluorophenyl)-2-methyl-thiazolyl) carbonyl)piperidine; obesity, type 2 diabetes, sleep disorders; strokes, blocking emetic response |
12/30/2008 | US7470709 Benzimidazole quinolinones and uses thereof |
12/30/2008 | US7470708 Acidic quinoline derivatives and their use for the prevention and/or treatment of hyperglycaemia-related pathologies |
12/30/2008 | US7470700 Such as 2-[2-(3-Amino-piperidin-1-yl)4-oxo-4H-quinazolin-3-ylmethyl]-benzonitrile; type 2 diabetes mellitus, diabetic dislipidemia, impaired glucose tolerance |
12/30/2008 | US7470699 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
12/30/2008 | US7470689 6-chloro-4-(3H-imidazo[4,5-c]pyridin-2-yl)-2H-pyridazin-3-one and and 4-(3H-imidazol [4,5-c]pyridin-2-yl)-6-pyridin-4-yl-2H-pyridazin-3-one; cyclin-dependent kinase inhibitor; anticarcinogenic, antitumor agent |
12/30/2008 | US7470685 e.g. 1-(2-(4-(N'-(3-Methyl-benzylidene)-hydrazino)-6-morpholin-4-yl-pyrimidin-2 -yloxy)-ethyl)-1H-pyridin-2-one; control interleukin production; antiinflammatory, antidiabetic agent; interleukin IL-12 overproduction-related disorder: rheumatoid arthritis, sepsis, Crohn's disease, multiple sclerosis |
12/30/2008 | US7470681 Pyrimidine compounds |
12/30/2008 | CA2429850C Ep4 receptor selective agonists in the treatment of osteoporosis |
12/30/2008 | CA2356300C 3-azabicyclo[3.1.0]hexane derivatives useful in therapy |
12/30/2008 | CA2245587C Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
12/30/2008 | CA2226256C New thrombin inhibitors, their preparation and use |
12/25/2008 | US20080319210 Method for purifying dianhydrides |
12/25/2008 | US20080319198 N-benzyl-N-{2-[7-(4-cyanobenzyl)-9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl]ethyl}methane-sulfonamide; trial and ventricular arrhythmias; pharmacokinetics; electrophysiological activity; lowering daily clinical dose, lengthening duration of action; side effect reduction |
12/25/2008 | US20080319022 2-Pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors |
12/25/2008 | US20080319021 Inhibition Of Phosphoinositide 3-Kinase Beta |
12/25/2008 | US20080319013 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazole-2-ones and, 4-(substituted cycloalkylmethyl) imidazole-2-ones and related compounds |
12/25/2008 | US20080319011 Protein tyrosine kinase enzyme inhibitors |
12/25/2008 | US20080319003 Cyclic amine compound and pest control agent |
12/25/2008 | US20080318967 Hair Growth Promoting Agents |
12/25/2008 | US20080318958 New utilities of tricyclic compounds |
12/25/2008 | US20080318944 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
12/25/2008 | US20080318903 Methods for treating cancer |
12/25/2008 | US20080318902 Triheterocyclic compounds and compositions thereof |
12/25/2008 | US20080317671 Non-imidazole heterocyclic compounds |
12/24/2008 | WO2008157500A1 Aminoquinazoline cannabinoid receptor modulators for treatment of disease |
12/24/2008 | WO2008157404A2 Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators |
12/24/2008 | WO2008157162A1 Dipeptide analogs as coagulation factor inhibitors |
12/24/2008 | WO2008156208A1 5-phenyl-3-pyridazinone derivative |
12/24/2008 | WO2008156105A1 Organic electroluminescence element material, organic electroluminescence element, display device and illuminating device |
12/24/2008 | WO2008156102A1 Pyrazolone derivative and pde inhibitor containing the same as active ingredient |
12/24/2008 | WO2008156094A1 Pyridazinone derivative and pde inhibitor containing the same as active ingredient |
12/24/2008 | WO2008156092A1 Azolylmethylidenehydrazine derivative and use thereof |
12/24/2008 | WO2008155081A2 Substituted aromatic heterocyclic compounds as fungicides |
12/24/2008 | WO2008155022A1 Pyrrole derivatives as p2y12 antagonists |
12/24/2008 | WO2008121861A3 Pyrazole and pyrrole compounds useful in treating iron disorders |
12/24/2008 | WO2008107481A8 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
12/24/2008 | WO2008104597A3 Sulfonyltryptophanols |